Zobrazeno 1 - 10
of 1 376
pro vyhledávání: '"Markus Graefen"'
Autor:
Mike Wenzel, Carolin Siech, Benedikt Hoeh, Florestan Koll, Clara Humke, Derya Tilki, Thomas Steuber, Markus Graefen, Séverine Banek, Luis A. Kluth, Felix K.H. Chun, Philipp Mandel
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 46-54 (2024)
Background and objective: With approval of novel systemic therapies within the past decade for metastatic hormone-sensitive (mHSPC) and castration-resistant (mCRPC) prostate cancer, patients may receive several therapy lines. However, the use of thes
Externí odkaz:
https://doaj.org/article/1758ca2edc274ae3ab0b726c095d034f
Autor:
Daimantas Milonas, Alexander Giesen, Tim Muilwijk, Charlotte Soenens, Gaëtan Devos, Zilvinas Venclovas, Alberto Briganti, Paolo Gontero, R. Jeffrey Karnes, Piotr Chlosta, Frank Claessens, Gert De Meerleer, Wouter Everaerts, Markus Graefen, Giansilvio Marchioro, Rafael Sanchez-Salas, Bertrand Tombal, Henk Van Der Poel, Hendrik Van Poppel, Martin Spahn, Steven Joniau
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 33-37 (2024)
International Society of Urological Pathology grade group 1 (GG 1) prostate cancer (PCa) is generally considered insignificant, with recent suggestions that it should even be considered as “noncancerous”. We evaluated outcomes for patients with G
Externí odkaz:
https://doaj.org/article/c8d0ad4edb444a3cbd022eb478d1fc4d
Autor:
Sergey A. Dyshlovoy, Wael Y. Mansour, Natalia A. Ramm, Jessica Hauschild, Maxim E. Zhidkov, Malte Kriegs, Alexandra Zielinski, Konstantin Hoffer, Tobias Busenbender, Ksenia A. Glumakova, Pavel V. Spirin, Vladimir S. Prassolov, Derya Tilki, Markus Graefen, Carsten Bokemeyer, Gunhild von Amsberg
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-17 (2024)
Abstract Fascaplysin is a red cytotoxic pigment with anticancer properties isolated from the marine sponge Fascaplysinopsis sp. Recently, structure–activity relationship analysis reported by our group suggested that selective cytotoxicity of fascap
Externí odkaz:
https://doaj.org/article/df82a4dc141245f18a09fe909aa98ef5
Autor:
Okyaz Eminaga, Fred Saad, Zhe Tian, Ulrich Wolffgang, Pierre I. Karakiewicz, Véronique Ouellet, Feryel Azzi, Tilmann Spieker, Burkhard M. Helmke, Markus Graefen, Xiaoyi Jiang, Lei Xing, Jorn H. Witt, Dominique Trudel, Sami-Ramzi Leyh-Bannurah
Publikováno v:
npj Imaging, Vol 2, Iss 1, Pp 1-12 (2024)
Abstract Malignancy grading of prostate cancer (PCa) is fundamental for risk stratification, patient counseling, and treatment decision-making. Deep learning has shown potential to improve the expert consensus for tumor grading, which relies on the G
Externí odkaz:
https://doaj.org/article/c4b8543e519440bb95cf3c3b228ab60d
Autor:
Randi M. Pose, Sophie Knipper, Jonas Ekrutt, Mara Kölker, Pierre Tennstedt, Hans Heinzer, Derya Tilki, Florian Langer, Markus Graefen
Publikováno v:
Asian Journal of Urology, Vol 11, Iss 1, Pp 42-47 (2024)
Objective: To examine the perioperative impact of factor V Leiden mutation on thromboembolic events' risk in radical prostatectomy (RP) patients. With an incidence of about 5%, factor V Leiden mutation is the most common hereditary hypercoagulability
Externí odkaz:
https://doaj.org/article/887f5dbeb65148c69d3cc6615ea86d8e
Autor:
Okyaz Eminaga, Fred Saad, Zhe Tian, Ulrich Wolffgang, Pierre I. Karakiewicz, Véronique Ouellet, Feryel Azzi, Tilmann Spieker, Burkhard M. Helmke, Markus Graefen, Xiaoyi Jiang, Lei Xing, Jorn H. Witt, Dominique Trudel, Sami-Ramzi Leyh-Bannurah
Publikováno v:
npj Imaging, Vol 2, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/6e50e8000ef34e08b3aaca7284d9f850
Autor:
Jan Philipp Radtke, Peter Albers, Boris A. Hadaschik, Markus Graefen, Christian P. Meyer, Björn Behr, Stephan Nüesch
Publikováno v:
Healthcare, Vol 12, Iss 10, p 991 (2024)
Background: Prostate cancer (PC) is the most common cancer in men in 112 countries, and accounts for 15% of cancers. Because it cannot be prevented, the rise in cases is inevitable, and improvements in diagnostic pathways and treatments are needed, a
Externí odkaz:
https://doaj.org/article/25351599a649485cb5c8a42008fdb739
Autor:
Carlo A. Bravi, Axel Heidenreich, Nicola Fossati, Giorgio Gandaglia, Nazareno Suardi, Elio Mazzone, Armando Stabile, Vito Cucchiara, Daniar Osmonov, Klaus‐Peter Juenemann, R. Jeffrey Karnes, Alexander Kretschmer, Alexander Buchner, Christian Stief, Andreas Hiester, Peter Albers, Gaëtan Devos, Steven Joniau, Hendrik Van Poppel, Bernhard Grubmüller, Shahrokh Shariat, Derya Tilki, Markus Graefen, Inderbir S. Gill, Alexander Mottrie, Pierre I. Karakiewicz, Francesco Montorsi, Alberto Briganti, David Pfister
Publikováno v:
BJUI Compass, Vol 4, Iss 1, Pp 123-129 (2023)
Abstract Objective To evaluate the relationship between pre‐operative PSA value, 68Ga‐prostate‐specific‐membrane‐antigen (PSMA) PET performance and oncologic outcomes after salvage lymph node dissection (sLND) for biochemical recurrent pros
Externí odkaz:
https://doaj.org/article/ee582f8d7c134c828ad73e0146499168
Autor:
Rocco Simone Flammia, Benedikt Hoeh, Francesco Chierigo, Lukas Hohenhorst, Gabriele Sorce, Zhen Tian, Costantino Leonardo, Markus Graefen, Carlo Terrone, Fred Saad, Shahrokh F. Shariat, Alberto Briganti, Francesco Montorsi, Felix K. H. Chun, Michele Gallucci, Pierre I. Karakiewicz
Publikováno v:
Current Urology, Vol 16, Iss 4, Pp 191-196 (2022)
Abstract. Background. The National Comprehensive Cancer Network (NCCN) guidelines recommend pelvic lymph node dissection (PLND) in NCCN high- and intermediate-risk prostate cancer patients. We tested for PLND nonadherence (no-PLND) rates within the S
Externí odkaz:
https://doaj.org/article/a56c9b8e0d404091b331323e993e7f0f
Autor:
Mykyta Kachanov, Malte W. Vetterlein, Armin Soave, Pierre I. Karakiewicz, Nikolaos Liakos, Thomas Jankowski, Randi M. Pose, Mikolaj Mendrek, Margit Fisch, Jorn H. Witt, Markus Graefen, Sami-Ramzi Leyh-Bannurah
Publikováno v:
The Aging Male, Vol 25, Iss 1, Pp 47-54 (2022)
Objective The aim of this study was to evaluate the prognostic impact of concomitant prostate cancer (PCa) of the cancer-specific mortality (CSM) in the aging patient’s papulation with bladder cancer (BCa) treated with radical cystoprostatectomy (R
Externí odkaz:
https://doaj.org/article/5892f786c9ed4eb6bb835ec2d135c477